1. Effect of brimonidine tartrate 0.15% on scotopic pupil size and upper eyelid position: controlled trial
- Author
-
Abdullah Karaca, Sinan Bilgin, Esat Cinar, Mehmet Ozgur Zengin, Cezmi Dogan, Mehmet Serhat Mangan, and Ibrahim Tuncer
- Subjects
Adult ,Male ,Miosis ,medicine.medical_specialty ,Adolescent ,genetic structures ,medicine.medical_treatment ,Article ,law.invention ,Young Adult ,Brimonidine Tartrate ,Randomized controlled trial ,law ,Quinoxalines ,Ophthalmology ,medicine ,Humans ,Scotopic vision ,Child ,business.industry ,Brimonidine ,Pupil size ,Eyelids ,Pupil ,Middle Aged ,eye diseases ,Artificial tears ,medicine.anatomical_structure ,Female ,sense organs ,Eyelid ,Ophthalmic Solutions ,medicine.symptom ,business ,medicine.drug - Abstract
BACKGROUND: To evaluate the effect of brimonidine tartrate 0.15% ophthalmic solution on pupil size under scotopic condition and upper eyelid position. METHODS: This study comprised 72 eyes of 36 healthy subjects. A single drop of brimonidine tartrate 0.15% ophthalmic solution was instilled in the right eye and artificial tear was instilled in the left eye. Pupil size was measured using an infra-red pupillometer under scotopic condition before and at 30 min, 2, 4, 6, 8 and 10 h after instillation. Measurement of margin reflex distance 1 (MRD1) was performed using a millimetre ruler before and after at 10 min after instillation. RESULTS: The mean age of the subjects was 32.19 ± 11.43 years (range 10–52 years), 17 were female and 19 were male. Before brimonidine instillation, the mean pupil size was 6.09 ± 1.03 mm in the brimonidine eyes and 6.06 ± 1.04 mm in the control eyes. There was a significant decrease in mean pupil size at 30 min (4.45 ± 1.04), 2 h (4.49 ± 1.06), 4 h (4.59 ± 1.06), 6 h (4.89 ± 1.06) and 8 h (5.38 ± 1.02) after instillation compared to before in brimonidine eyes (p
- Published
- 2020
- Full Text
- View/download PDF